Literature DB >> 20883545

The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables.

M Mengel1, B Sis, D Kim, J Chang, K S Famulski, L G Hidalgo, G Einecke, D G de Freitas, W Tymchak, J Burton, P F Halloran.   

Abstract

Histopathology of endomyocardial biopsies (EMB) is the standard rejection surveillance for heart transplants. However, ISHLT consensus criteria for interpreting biopsies are arbitrarily defined. Gene expression offers an independent re-evaluation of existing diagnostic systems. We performed histologic and microarray analysis on 105 EMB from 45 heart allograft recipients. Histologic lesions, diagnosis and transcripts were compared to one another, time posttransplantation, indication for biopsy and left ventricular ejection fraction (LVEF). Histologic lesions presented in two groups: myocyte-interstitial and microcirculation lesions. Expression of transcript sets reflecting T cell and macrophage infiltration, and γ-interferon effects correlated strongly with each other and with transcripts indicating tissue/myocardium injury. This molecular phenotype correlated with Quilty (p < 0.005), microcirculation lesions (p < 0.05) and decreased LVEF (p < 0.007), but not with the histologic diagnosis of rejection. In multivariate analysis, LVEF was associated (p < 0.03) with γ-interferon inducible transcripts, time posttransplantation, ischemic injury and clinically indicated biopsies, but not the diagnosis of rejection. The results indicate that (a) the current ISHLT system for diagnosing rejection does not reflect the molecular phenotype in EMB and lacks clinical relevance; (b) the interpretation of Quilty lesions has to be revisited; (c) the assessment of molecules in heart biopsy can guide improvements of current diagnostics.
© 2010 The Authors Journal compilation © 2010 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883545     DOI: 10.1111/j.1600-6143.2010.03182.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  19 in total

Review 1.  B cells in cardiac transplants: from clinical questions to experimental models.

Authors:  William M Baldwin; Marc K Halushka; Anna Valujskikh; Robert L Fairchild
Journal:  Semin Immunol       Date:  2011-09-19       Impact factor: 11.130

Review 2.  Immune modulation in heart failure: past challenges and future hopes.

Authors:  Jose H Flores-Arredondo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Heart Fail Rep       Date:  2011-03

3.  Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection?

Authors:  Kevin P Daly
Journal:  Ann Transl Med       Date:  2015-03

4.  Molecular patterns in human ulcerative colitis and correlation with response to infliximab.

Authors:  Brendan Halloran; Jessica Chang; David Q Shih; Dermot McGovern; Konrad Famulski; Chad Evaschesen; Richard N Fedorak; Aducio Thiesen; Stephan Targan; Philip F Halloran
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 5.  Updates on Heart Transplantation.

Authors:  Kevin S Shah; Michelle M Kittleson; Jon A Kobashigawa
Journal:  Curr Heart Fail Rep       Date:  2019-10

6.  Endomyocardial biopsy for monitoring heart transplant patients: 11-years-experience at a german heart center.

Authors:  Thomas Strecker; Johannes Rösch; Michael Weyand; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

Review 7.  Genetics of acute rejection after kidney transplantation.

Authors:  Casey R Dorr; William S Oetting; Pamala A Jacobson; Ajay K Israni
Journal:  Transpl Int       Date:  2017-11-08       Impact factor: 3.782

8.  Identification and classification of acute cardiac rejection by intragraft transcriptional profiling.

Authors:  Cécile T J Holweg; Luciano Potena; Helen Luikart; Tianwei Yu; Gerald J Berry; John P Cooke; Hannah A Valantine; Edward S Mocarski
Journal:  Circulation       Date:  2011-05-09       Impact factor: 29.690

9.  Exploring the cardiac response to injury in heart transplant biopsies.

Authors:  Philip F Halloran; Jeff Reeve; Arezu Z Aliabadi; Martin Cadeiras; Marisa G Crespo-Leiro; Mario Deng; Eugene C Depasquale; Johannes Goekler; Xavier Jouven; Daniel H Kim; Jon Kobashigawa; Alexandre Loupy; Peter Macdonald; Luciano Potena; Andreas Zuckermann; Michael D Parkes
Journal:  JCI Insight       Date:  2018-10-18

10.  The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care.

Authors:  Mario C Deng
Journal:  Expert Rev Precis Med Drug Dev       Date:  2020-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.